ArticleThe Journal of clinical investigation2014

Impaired kisspeptin signaling decreases metabolism and promotes glucose intolerance and obesity.

Kristen P Tolson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.